U.S. NeuroSurgical Holdings, Inc.
USNU · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $12,302 | $4,178 | $863 | $1,792 |
| - Cash | $4,034 | $466 | $1,537 | $2,178 |
| + Debt | $72 | $85 | $23 | $66 |
| Enterprise Value | $8,340 | $3,797 | -$651 | -$320 |
| Revenue | $0 | $0 | $0 | $1,061 |
| % Growth | – | – | -100% | – |
| Gross Profit | -$13 | -$20 | -$39 | $975 |
| % Margin | – | – | – | 91.9% |
| EBITDA | -$2,205 | -$49 | -$1,494 | -$515 |
| % Margin | – | – | – | -48.5% |
| Net Income | -$2,055 | -$816 | -$1,572 | -$881 |
| % Margin | – | – | – | -83% |
| EPS Diluted | -0.13 | -0.088 | -0.17 | -0.11 |
| % Growth | -47.9% | 48.3% | -54.5% | – |
| Operating Cash Flow | -$1,515 | -$891 | -$1,413 | $174 |
| Capital Expenditures | $0 | $0 | -$772 | $0 |
| Free Cash Flow | -$1,515 | -$891 | -$2,185 | $174 |